about
Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.Early Development of Symptomatic Drugs in AD: A Systematic Review of the Use of Biomarkers.Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects.Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.Hypothalamic activation in spontaneous migraine attacks.PET scan perfusion imaging in the Prader-Willi syndrome: new insights into the psychiatric and social disturbances.The management of patients with early Parkinson's disease.Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old manCerebral hemodynamic changes induced by a lumbar puncture in good-grade subarachnoid hemorrhage.KBA.62: a useful marker for primary and metastatic melanomas.Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects.Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.Amyloid imaging in Alzheimer's disease: a literature review.Radiolabelling rituximab with (99m)Tc in three steps procedure.The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader-Willi Syndrome.Molecular imaging in the diagnosis of Alzheimer's disease and related disorders.[Positron emission tomographic studies of migraine]Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study.Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study.Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.Imaging grafted cells with [18F]FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model.Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly.Impact of the point spread function on maximum standardized uptake value measurements in patients with pulmonary cancer.Abstracts from Hydrocephalus 2016.Discordance between labelled white blood cell scintigraphy and bone scan following suspicion of bone infection: what should be done about it?Toxicological methods for tracing drug abuse: chromatographic, spectroscopic and biological characterisation of ecstasy derivatives.(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.[Management of levodopa-induced dyskinesia]Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia.PT593. CSF Beta-Amyloid and APOE E4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study.Association of Cortical β-Amyloid with Erythrocyte Membrane Monounsaturated and Saturated Fatty Acids in Older Adults at Risk of Dementia.Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia.Brain Networks are Independently Modulated by Donepezil, Sleep, and Sleep Deprivation.Enhancing Plasticity of the Central Nervous System: Drugs, Stem Cell Therapy, and Neuro-Implants.New PET markers for the diagnosis of dementia.A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.
P50
Q30403393-5F87400B-3EEC-4CFE-97CD-97A2279BB467Q31027253-8C731429-D4E6-45A1-9DD5-0C3507031560Q31096945-40460896-B846-4928-81B1-6E6BD1F2F7A6Q31121409-9C519C18-B10D-4E15-8B3D-5C293D57EF53Q33604453-F001F7BC-2F2E-4D81-BAAA-36C731AD6588Q34585622-AE1F24D1-FF75-4C5D-A1EE-C0A76707EAFFQ34627542-F04802CF-4A02-4A7E-B4A1-D4E0BD9E734BQ34826166-9D4F47D6-15E2-4C6B-A7A6-56BD9B8F8868Q35861376-A80CC27B-4F81-4883-9B1E-C4895D23B536Q36090731-D1A473E3-16A2-4C20-95EB-5560EFC3446EQ36383034-5B788C6F-B63D-4984-9794-821B1A48B3F7Q37169883-D5BA4E1C-3DBD-4C36-9071-38A355926A28Q37402288-9B52CC5B-D28E-4DFE-BCB5-18708629AF2EQ37689338-5111B1EB-E79A-4FD4-AE17-CCDCC6FC3E23Q38250091-C7366335-4A3A-4872-B488-4453ED75FACBQ38870324-72F985B9-14C7-4960-AD99-AB2AAF08D995Q39013783-81B27051-E7AD-4EA2-B4F0-B83722897FAAQ39014671-510F91E4-302B-44DE-A608-A1DC830B4255Q39362450-B07D483B-D9E5-4BA1-AB00-9D2AE1C3F373Q39464885-596A3063-0A31-44D6-8773-00794E1D94DDQ40339348-547BF034-3BA5-41ED-BF34-E01F8265DF0CQ40748803-203FA58E-0362-41DD-84D4-7FFC265FC89CQ40873275-F423D718-B74C-4955-A0F8-3F8494051733Q41677368-70637299-9405-4830-82F1-21E27A02852CQ41693604-2F2328A8-CADD-45D7-946E-7D3D5AD90217Q42069874-1020B517-30E2-40ED-9079-8E8A313B74DAQ42201295-9FB7C355-AF43-4469-A0C0-D5E5AC0E0B8BQ42779434-97AF9097-04AE-49D3-B277-59324A6072D3Q43118350-866464EB-1626-4C5F-B30B-DC820CCA5122Q43498641-C8E0D4E5-5354-458A-BE2C-BAD01593F433Q44400413-E1997C14-AD33-476F-9C66-CE47D3F21979Q45303000-5F30DD74-5DF2-4772-A55F-C0D08D59DAF9Q45762974-3E1A19DA-7695-4D51-AD30-939A5C3EA4D6Q45798218-2DEFBAE4-B199-4718-AA83-CEE80821C8AEQ47393273-9EA18388-EB6F-4C2B-839C-96F6E5F29D13Q47393332-0ABE087E-02ED-4D34-9E0F-CC9F1B9880CBQ47420940-E9033632-E841-45C9-A7B1-E890D561A0D7Q47698235-99F77089-52F1-4BF5-ABBD-CF7BB93E56A6Q47803884-0CB19AE2-C760-4C38-BD27-8ADDAF9446E5Q48132965-EE7A6BF3-F56C-4EF9-B6AB-3FE61BCD811A
P50
description
researcher
@en
name
Pierre Payoux
@en
Pierre Payoux
@nl
type
label
Pierre Payoux
@en
Pierre Payoux
@nl
prefLabel
Pierre Payoux
@en
Pierre Payoux
@nl
P106
P31
P496
0000-0002-1374-1620